Deep Transcranial Magnetic Stimulation at Katie’s Way
Katie's Way is revolutionizing the treatment of depression with deep transcranial magnetic stimulation. If you have been diagnosed with major depressive disorder (MDD) or suffer from PTSD with associated MDD and have tried one or more antidepressant medications without relief, then deep TMS from Katie’s Way could be the answer for you.
What is Deep TMS?
Deep Transcranial Magnetic Stimulation, or dTMS, is an FDA-approved, non-invasive treatment option that offers long-term relief for major depression. This revolutionary treatment uses magnetic fields to stimulate areas of the brain that control mood and are underactive in people with depression. This technology is available at Katie’s Way. With dTMS you can regain a sense of well-being and enjoy a better quality of life in just a few weeks.
How Does Deep TMS Work?
The treatment fully integrates into your routine. You are comfortably seated on a chair during each session, and a cushioned helmet is placed over your head. The helmet uses magnetic fields to stimulate the targeted brain area and improve depressive symptoms. The procedure requires daily sessions for 20 minutes for 6 weeks. The treatment does not require hospitalization or anesthesia. You can return to your regular routine after each treatment.
Is Deep TMS Safe and Effective?
BrainsWay uses Deep TMS technology, which has been tested in over 60 clinical studies for various indications in leading institutions worldwide. The FDA has cleared this technology for clinical use in Major Depressive Disorder and it is currently available in the US, Europe, and South America*. Over 15,000 patients have already been treated with BrainsWay including hundreds of patients at Katie’s Way!
An Effective Treatment for Depression in Manhattan
Over 70% of patients treated with deep TMS at Katie’s Way experienced a 50% decrease or more in their symptoms. With a treatment that integrates seamlessly into your routine, you too can have the same results.
TMS for Military and Veterans
Katie’s Way is a proud supporter of our nation’s military and veterans. With our proximity to Fort Riley and the Big Red One, Katie’s Way has the privilege of being a service provider to active duty personnel, veterans, and their dependents. Katie’s Way accepts Tricare and is a VA Choice Community Care Provider. Transcranial magnetic stimulation is an excellent treatment option for the military and veteran community suffering from Depression or Post Traumatic Stress Disorder (PTSD). Learn More.
A Clinically Superior Treatment
Deep TMS Increases Remission Rates in Depression
“60% Remission of Depression with Deep TMS vs. 11% with Medication Alone.”
Transcranial Magnetic Stimulation (TMS) is a noninvasive treatment that uses magnetic fields to regulate the activity of brain structures found to be related to different mental health conditions. As the treatment itself relies on repeated pulses of magnetic fields, it is sometimes referred to as repetitive TMS, or rTMS.
At present, there are two major kinds of TMS therapy publicly available to treat mental health conditions: the above-mentioned Traditional rTMS; and the more advanced Deep TMS.
The only independent, head-to-head study of TMS technologies, published in the Journal of Psychiatric Research*, determined that deep TMS plus standard medication was significantly more effective at reducing depression levels among Major Depressive Disorder (MDD) patients compared with Traditional figure-8 TMS plus medication or medication alone.*
Deep TMS had no difference in safety or tolerability from Traditional TMS.
Deep TMS technology, used at Katie’s Way, enables non-invasive activation of deeper and broader brain structures than traditional figure-8 coil TMS systems, allowing the H-Coil (deep TMS) to address a wider area of the brain.
With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. Deep TMS uses a unique coil design that allows for the strength of stimulation to be maintained at effective levels in regions deeper within the brain.
A meta analysis confirmed by BMC Psychiatry* showed showed the comparison between coils indicated a larger reduction in depression severity in deep TMS compared to that of traditional figure-8 coils.
“When matched on frequency, deep TMS or H Coils, reduces depression more than the lower-intensity and more focal stimulation with traditional TMS or figure-8 coils.”
Katie’s Way TMS Medical Team
See What Real Patients Have to Say
“I can honestly say that I have benefited from the treatments more from the last few weeks, over the 15 years of medication.”
“My life has gone from a series of mostly neutral to bad, to I didn’t have a bad day for over a month!”
“Within 2-3 sessions my sleep begin to regulate and that was massive! That took the edge off the depression immediately. ”
“I actually started to notice I was going to sleep at night. I wasn’t laying there for hours every night.”
Contact Us Today to Start Feeling Better
Don’t Let Depression Hold You Back
Who Can receive TMS?
BrainsWay deep TMS is approved for patients aged 18 or older who have been diagnosed with major depressive disorder (MDD).
How effective is TMS?
In real-life clinical settings*, the treatment was proven to be effective for 3 out of 4 patients, with a 51% remission rate and 75% response rate and has been used to help PTSD with associated MDD as well.
I have already tried other medications. How is this any better?
Studies have shown the treatment to be effective for patients with depression, no matter how many other medications were tried in the current depressive episode.
Is treatment uncomfortable?
BrainsWay is a non-invasive procedure, which eliminates the need for hospitalization. Patients may experience minor side effects such as headaches or minor pain at the site of the treatment. However, this is usually brief and ceases after the first few sessions.
Has TMS been tested?
BrainsWay uses Deep TMS technology, which has been tested in over 60 clinical studies for various indications in leading institutions worldwide. The FDA has cleared this technology for clinical use in Major Depressive Disorder and it is currently available in the US, Europe and South America*. Over 15,000 patients have already been treated with BrainsWay.
What should I expect during treatment?
The treatment integrates seamlessly into your routine. During each session, you are comfortably seated on a chair and a cushioned helmet is placed over your head. The helmet uses magnetic fields to stimulate the targeted brain area and improve depressive symptoms. The procedure requires daily sessions of 20 minutes for 4-6 weeks. As the treatment does not require hospitalization or anesthesia, and entails no memory loss and no systemic side effects, you can return to your normal routine after each session.
Still Have Questions?
Contact Katie’s Way and our TMS Coordinator, Katie, today!
Phone: 785-320-2908
Email: kpayne2@katieswaymanhattan.com
720 Poyntz Avenue
Manhattan, KS, 66502
United States
Other Locations:
Deep TMS is also available from Katie’s Way TMS in El Paso Texas!
* Remission Response Rates: In the multicenter trial that led to BrainsWay's FDA clearance for MDD, 1 in 3 medication-resistant patients achieved full remission and 38.4% achieved a positive response. Real life settings have shown significantly better results. Data on file.
* Indication: BrainsWayD is indicated by the FDA for the treatment of depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode. FDA 510(k) No. K 122288.
*Journal of Psychiatric Research, Volume 114, July 2019, Pages 113-119 of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial.
*Gellersen HM, Kedzior KK. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):139. Published 2019 May 7. doi:10.1186/s12888-019-2106-7